Information Provided By:
Fly News Breaks for March 27, 2015
ESPR
Mar 27, 2015 | 06:07 EDT
Citigroup says it sees an unmet need for Esperion's oral LDL cholesterol lowering agent ETC-1002. It assumed coverage of the stock with a Buy rating and raised its price target for shares to $130 from $67.
News For ESPR From the Last 2 Days
ESPR
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here
ESPR
Mar 27, 2024 | 10:47 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here